Migrastatic therapy as a potential game-changer in adaptive cancer treatment.

Adaptive therapy, which anticipates and counters the evolution of resistance in cancer cells, has gained significant traction, especially following the success of the Zhang et al.'s protocol in treating metastatic castrate-resistant prostate cancer.…

Preview only. Read the full abstract at the source